Work

Biomarker Proteasome Levels Predict Response to Combination Therapy with Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.2080.2080

Authors: Neha Korde, Talib Dosani, Olga Simakova, Sham Mailankody, Rene Costello, Mark Roschewski, Constance Yuan, Maryalice Stetler-Stevenson, William D Figg, Ola Landgren, Irina Maric

Institutions: Memorial Sloan Kettering Cancer Center, National Institutes of Health, National Institutes of Health Clinical Center, National Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2490123693

FWCI:

Cites:

Cited by: 1

Related to: 10